EPCAM and ovarian neoplasm: Research on EpCAM-specific EVs might also shed light on the contradictory results of the immunohistochemical evaluation of EpCAM overexpression in ovarian tumors in relation to its prognostic value, in terms of overall survival and response to chemotherapy [20,21,25,26].